Meja et al. [43] found that a significant portion of primary AML samples showed PIM1 and PIM2 expression, and thus examined the effect of pan-PIM inhibitor AZD1897 on AML cell growth and survival. Here, PIM1 is linked to acute myeloid leukemia.